Bone Fracture

Data from the FDA Adverse Reporting System revealed an association between the use of GLP-1 receptor agonists and the onset of acute cholecystitis.

According to a recent study, higher body fat in adults was associated with a higher risk for all-cause mortality.

Vitamin D3 supplementation is not associated with a reduced risk for fractures among healthy middle-aged and older adults, according to study results published in The New England Journal of Medicine.

A newly developed malnutrition-inflammation complex syndrome score revealed an association between a high score and increased risks of bone-cardiovascular axis disorders in patients receiving maintenance hemodialysis.

The Healio and Endocrine Today editors have compiled the top news about bone and mineral metabolism in 2021.

Phase 3 study results of lumasiran to treat advanced primary hyperoxaluria type 1 showed a significant reduction in plasma oxalate and “pre-dialysis” plasma oxalate from baseline to 6 months, a speaker at ASN Kidney Week said.

Variables added to adjust the Fracture Risk Assessment Tool for recent fractures overestimated risk in a cohort of older women from Canada, according to a speaker.

Vitamin D3 supplementation did not reduce fracture risk in a large cohort of U.S. adults not selected for vitamin D deficiency or osteoporosis, according to an ancillary analysis of the VITAL trial.

A 72-year-old woman was originally seen by her primary care physician for left wrist pain after a ground level fall. Due to persistent pain and swelling, the patient underwent radiographs.

It will be “many years” before any new pharmacologic osteoporosis therapies are approved, as there are currently no new drugs in phase 2 or 3 development, according to a speaker at the 2021 Congress of Clinical Rheumatology-East meeting.